BioSpace News Archive

DreaMed Diabetes AI LTD. (“DreaMed” or the “Company”), a developer of the Advisor Pro Al Clinical Decision Support System expert-care platform for diabetes, announced today that it has received its 4th U.S Food and Drug Administration (FDA) clearance that expands the platform’s target population to patients with both type 1 and type 2 diabetes.

Psygen is excited to announce that psilocybin recently used in a clinical trial was manufactured using Psygen’s patent-pending synthetic method.

Kazia Therapeutics Limited is pleased to announce that CEO, Dr James Garner , will be presenting at the LD Micro Main Event, to be held virtually and in person from 12-14 October 2021

Todos Medical, Ltd. (“Todos Medical”) (OTCQB: TOMDF), today announced positive clinical validation data for its 3CL protease biomarker assay TolloTest™ in a clinical study evaluating its sensitivity compared with PCR in hospitalized COVID-19 patients.

Amplo Biotechnology today announced the successful closing of an undisclosed Series Seed financing.

Compounded drugs can serve an important role for patients whose medical needs cannot be met by an FDA-approved drug.

PreciseMDX, the leading end-to-end digital health platform for laboratories that automates and simplifies the diagnostic testing experience, announces today digital shipping kits for at-home or on-site diagnostic tests designed to streamline testing for patients, labs, and clinicians.

Canon Medical announced that due to recent developments in the Covid-19 pandemic, it will be attending all further relevant, major US-based global conferences in 2021, with a digital presence only.

ReCor Medical, Inc. (“ReCor”), a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., announced today that the company’s Paradise™ Ultrasound Renal Denervation System (the “Paradise™ System”) is now available for the treatment of uncontrolled hypertension in Germany.

Biotricity Inc., a medical diagnostic and consumer healthcare technology company, announced it will be ringing the Opening Bell on the Nasdaq Stock Market on Thursday, October 7, 2021 at 9:30am E.T.